Experts Disagree Over Whether FDA Has Authority For Pre-Cert

By David Roza / January 10, 2019 at 1:10 PM
Device industry experts disagree over whether a suite of new documents related to FDA’s nascent medical software precertification program answers a key question posed by stakeholders: Does the agency have statutory authority to implement pre-cert? Aaron Josephson, a senior director at ML Strategies and former senior policy advisor at FDA’s device center, said the agency does provide a satisfying answer to the question by rooting its authority for pre-cert in its de novo device review process. However, Brad Thompson, a...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.